The Predictive Value of Alarm Symptoms in Patients With Dyspepsia Based on Roman IV
1 other identifier
observational
800
1 country
1
Brief Summary
Functional dyspepsia is one of the most common gastrointestinal disorders (FGIDs) encountered in clinical practice.Clinical diagnosis is notoriously unreliable in diagnosing the underlying cause of dyspepsia,but a number of alarm features have been suggested as indicating patients at higher risk for serious disease. The predictive value of alarm symptoms still require more researches. Rome IV introduced more precisely define the minimal thresholds for frequency and severity of each individual symptom, primarily for scientific purposes,but data still need to be collected to define thresholds based on the frequency and/or severity of symptoms that impair quality of life.A cross-sectional study was conducted to assess the predictive value of alarm symptoms in patients with dyspepsia based on Roman IV.Through endoscopy results to determine whether dyspepsia is organic or functional, benign or malignant, through contacts with the basic data, to determine the alarm symptoms
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2018
CompletedFirst Submitted
Initial submission to the registry
March 8, 2018
CompletedFirst Posted
Study publicly available on registry
March 27, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2019
CompletedJanuary 14, 2019
February 1, 2018
11 months
March 8, 2018
January 10, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The incidence of organic dyspepsia.
To collect the results of gastroscopy in patients who meet inclusion criteria, and to calculate the incidence of organic dyspepsia to analyze the predictive value of alarm symptoms.
3 months
Secondary Outcomes (1)
The incidence of gastric cancer
3 months
Study Arms (1)
Dyspepsia
All patients who were satisfied with the inclusion criteria and exclusion criteria in the department of the second affiliated hospital of Xi'an jiaotong university,Xijing Hospital, Tangdu Hospital, Xi'an No.3 Hospital, and received investigation.
Eligibility Criteria
From March 2018 to August 2018 ,patient went to the Gastroenterology clinics of the second affiliated hospital of xi'an jiaotong university, Xijing Hospital, Tangdu Hospital, Xi'an No.3 Hospital, and received gastroscopy.
You may qualify if:
- Aged 18 years and older;
- Presence of dyspeptic symptoms according with Rome IV criteria (Discomfort was characterized by the presence of one or more symptoms that included bothersome postprandial fullness, bothersome early satiation, bothersome epigastric pain, bothersome epigastric burning, Symptoms had to be present for at least 3 months within the preceding 6 months);
- From March 2018 to January 2019, patient went to the Gastroenterology clinics of the second affiliated hospital of xi'an jiaotong university, Xijing Hospital, Tangdu Hospital, Xi'an No.3 Hospital, and received gastroscopy;
- Upper abdominal ultrasonography, blood routine examination, liver function test were conducted within six months.
You may not qualify if:
- History of esophagitis or ulcer disease or other organic upper gastrointestinal disease, pancreaticobiliary disease, metabolic disease(abnormal thyroid function, diabetes );
- Were pregnant, might become pregnant, or were lactating;
- Major abdominal surgery;
- Severe neurological disorder, psychological diseases; or with severe hepatic, renal or respiratory dysfunction;
- Known or suspected liver dysfunction, including NASH, HBV or HCV-related hepatitis;
- History of gastroscope within 1 year;
- (6) Current antidepressant, steroids or NSAID use; (7) Patients who had only reflux-related symptoms or who had predominantly reflux-related symptoms; (8) Not willing to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Second Affiliated Hospital of Xi'an Jiaotong Universitylead
- Xijing Hospitalcollaborator
- Tang-Du Hospitalcollaborator
- Xi'an No.3 Hospitalcollaborator
Study Sites (1)
The second affiliated hospital of xi'an jiaotong university
Xi’an, Shanxi, 710004, China
Related Publications (2)
Wei Z, Yang Q, Yang Q, Yang J, Tantai X, Xing X, Xiao C, Pan Y, Liu N, Wang J. Rome III, Rome IV, and Potential Asia Symptom Criteria for Functional Dyspepsia Do Not Reliably Distinguish Functional From Organic Disease. Clin Transl Gastroenterol. 2020 Dec;11(12):e00278. doi: 10.14309/ctg.0000000000000278.
PMID: 33512804DERIVEDWei ZC, Yang Q, Yang Q, Yang J, Tantai XX, Xing X, Xiao CL, Pan YL, Wang JH, Liu N. Predictive value of alarm symptoms in patients with Rome IV dyspepsia: A cross-sectional study. World J Gastroenterol. 2020 Aug 14;26(30):4523-4536. doi: 10.3748/wjg.v26.i30.4523.
PMID: 32874062DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jinhai Wang, MD
The Second Affiliated Hospital of Xi'an Jiaotong University,Xi'an, Shaanxi, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 8, 2018
First Posted
March 27, 2018
Study Start
March 1, 2018
Primary Completion
January 31, 2019
Study Completion
January 31, 2019
Last Updated
January 14, 2019
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will not share